134 related articles for article (PubMed ID: 12739759)
1. Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
Wang EJ; Casciano CN; Clement RP; Johnson WW
Pharm Res; 2003 Apr; 20(4):537-44. PubMed ID: 12739759
[TBL] [Abstract][Full Text] [Related]
2. Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
Wang EJ; Casciano CN; Clement RP; Johnson WW
Biochem Biophys Res Commun; 2001 Nov; 289(2):580-5. PubMed ID: 11716514
[TBL] [Abstract][Full Text] [Related]
3. Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence.
Wang EJ; Casciano CN; Clement RP; Johnson WW
Biochim Biophys Acta; 2000 Aug; 1481(1):63-74. PubMed ID: 10962093
[TBL] [Abstract][Full Text] [Related]
4. Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.
Wang E; Lew K; Barecki M; Casciano CN; Clement RP; Johnson WW
Chem Res Toxicol; 2001 Dec; 14(12):1596-603. PubMed ID: 11743742
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
6. Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors.
Kis E; Ioja E; Nagy T; Szente L; Herédi-Szabó K; Krajcsi P
Drug Metab Dispos; 2009 Sep; 37(9):1878-86. PubMed ID: 19520776
[TBL] [Abstract][Full Text] [Related]
7. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump.
Ballatori N; Rebbeor JF; Connolly GC; Seward DJ; Lenth BE; Henson JH; Sundaram P; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G57-63. PubMed ID: 10644562
[TBL] [Abstract][Full Text] [Related]
8. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
9. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors.
Byrne JA; Strautnieks SS; Mieli-Vergani G; Higgins CF; Linton KJ; Thompson RJ
Gastroenterology; 2002 Nov; 123(5):1649-58. PubMed ID: 12404239
[TBL] [Abstract][Full Text] [Related]
10. The vesicular transport assay: validated in vitro methods to study drug-mediated inhibition of canalicular efflux transporters ABCB11/BSEP and ABCC2/MRP2.
Herédi-Szabó K; Kis E; Krajcsi P
Curr Protoc Toxicol; 2012 Nov; Chapter 23():Unit 23.4. PubMed ID: 23169269
[TBL] [Abstract][Full Text] [Related]
11. More relevant prediction for in vivo drug interaction of candesartan cilexetil on hepatic bile acid transporter BSEP using sandwich-cultured hepatocytes.
Fukuda H; Nakanishi T; Tamai I
Drug Metab Pharmacokinet; 2014; 29(1):94-6. PubMed ID: 23877105
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.
Te Brake LH; Russel FG; van den Heuvel JJ; de Knegt GJ; de Steenwinkel JE; Burger DM; Aarnoutse RE; Koenderink JB
Tuberculosis (Edinb); 2016 Jan; 96():150-7. PubMed ID: 26682943
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Lempers VJ; van den Heuvel JJ; Russel FG; Aarnoutse RE; Burger DM; Brüggemann RJ; Koenderink JB
Antimicrob Agents Chemother; 2016 Jun; 60(6):3372-9. PubMed ID: 27001813
[TBL] [Abstract][Full Text] [Related]
15. Lack of Interactions Between an Antisense Oligonucleotide with 2'-O-(2-Methoxyethyl) Modifications and Major Drug Transporters.
Yu RZ; Warren MS; Watanabe T; Nichols B; Jahic M; Huang J; Burkey J; Geary RS; Henry SP; Wang Y
Nucleic Acid Ther; 2016 Apr; 26(2):111-7. PubMed ID: 26959999
[TBL] [Abstract][Full Text] [Related]
16. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Morgan RE; Trauner M; van Staden CJ; Lee PH; Ramachandran B; Eschenberg M; Afshari CA; Qualls CW; Lightfoot-Dunn R; Hamadeh HK
Toxicol Sci; 2010 Dec; 118(2):485-500. PubMed ID: 20829430
[TBL] [Abstract][Full Text] [Related]
17. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
[TBL] [Abstract][Full Text] [Related]
18. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
Graber-Maier A; Gutmann H; Drewe J
Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
[TBL] [Abstract][Full Text] [Related]
19. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
[TBL] [Abstract][Full Text] [Related]
20. Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity.
Rijpma SR; van den Heuvel JJ; van der Velden M; Sauerwein RW; Russel FG; Koenderink JB
Malar J; 2014 Sep; 13():359. PubMed ID: 25218605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
